083790 CG인바이츠

기본 정보

  • 섹터: KOSDAQ:일반서비스
  • 시가총액: 773억원 (2026-06-30 기준)
  • 첫 등장: 2026-06-02 (누적 1일)
  • 태그: 매크로/IT소프트웨어 · 매크로/바이오헬스 · 바이오 · 유전체분석 · AI헬스케어 · 정밀의료 · 신약
  • 네이버 금융: 🔗

기업개요

  • 동사는 2000년 설립, 2023년 씨지인바이츠로 변경 및 2006년 코스닥 상장한 바이오 기업임.
  • 유전체/의약품개발, AI헬스케어솔루션, 온열패치 제조하며 구조 기반 신약 연구개발 기술 보유, ‘아셀렉스’ 국내 22호 신약 허가받아 판매 중임.
  • 디지털 유전체 기업으로 도약, AI·빅데이터 분석 역량으로 질환 예측 알고리즘 고도화 및 정밀의료 플랫폼 구축 추진하고 있음.

출처: 네이버증권 종목분석 (WiseReport)

일자별 등장 (최신 위, 누적)

일자전일 종가종가등락률시간외vol색깔smart금투그외
2026-08-14864835🔵 -3.36%×0.5🔻 개인-0.0억-0.0+0.0+0.0+0.0+0.0+0.0
2026-08-13890864🔵 -2.92%×0.4🔻 개인-0.1억-0.1+0.0+0.0+0.0+0.1+0.0
2026-08-12900890🔵 -1.11%×0.8🔻 개인-0.2억-0.2+0.0+0.1+0.0+0.1+0.0
2026-08-11972900🔵 -7.41%×0.9🔻 개인-0.2억-0.2+0.0+0.0+0.0+0.2+0.0
2026-08-10994972🔵 -2.21%×0.9🔻 개인-0.6억-0.6+0.0+0.0+0.0+0.6+0.0
2026-08-071,015994🔵 -2.07%×2.8⚫ 그외-0.3억-0.3+0.0+0.0+0.0-0.5+0.8
2026-08-068951,015🔴 +13.41%×2.5⚫ 그외+0.2억+0.2+0.0+0.0+0.0-1.6+1.5
2026-08-05860895🔴 +4.07%×0.6🔻 개인-0.2억-0.2+0.0+0.0+0.0+0.2+0.0
2026-08-04812860🔴 +5.91%×1.4🟢 외인+0.6억+0.6+0.0+0.0+0.0-0.6+0.0
2026-08-03762812🔴 +6.56%×1.2🟢 외인+0.4억+0.4+0.0+0.0+0.0-0.4+0.0
2026-07-31744762🔴 +2.42%×0.9🟢 외인+0.2억+0.2+0.0+0.0+0.0-0.2+0.0
2026-07-30770744🔵 -3.38%×0.6🟢 외인+0.2억+0.2+0.0+0.0+0.0-0.2+0.0
2026-07-29777770🔵 -0.90%×1.4🔻 개인-0.3억-0.3+0.0+0.0+0.0+0.1+0.1
2026-07-28809777🔵 -3.96%×0.7🔻 개인-0.4억-0.4+0.0+0.0+0.0+0.4+0.0
2026-07-27770809🔴 +5.06%×2.0🟢 외인+0.6억+0.6+0.0+0.0+0.0-0.6+0.0
2026-07-24774770🔵 -0.52%×0.8🔻 개인-0.1억-0.1+0.0+0.0+0.0+0.1+0.0
2026-07-23823774🔵 -5.95%×0.8🔻 개인-0.2억-0.2+0.0+0.0+0.0+0.3-0.0
2026-07-22846823🔵 -2.72%×0.2🔻 개인-0.1억-0.1+0.0+0.0+0.0+0.1+0.0
2026-07-21846846⚪ +0.00%×0.5🔻 개인-0.0억-0.0+0.0+0.0+0.0+0.0+0.0
2026-07-20884846🔵 -4.30%×0.2🔻 개인+0.0억+0.0+0.0+0.0+0.0+0.0+0.0
2026-07-16887884🔵 -0.34%×1.0🟢 외인+0.3억+0.3+0.0-0.0+0.0-0.3+0.0
2026-06-251,0011,025🔴 +2.40%×0.6⚫ 그외-0.2억-0.2+0.0+0.0-0.5+0.7
2026-06-241,0201,001🔵 -1.86%×1.1⚫ 그외-0.1억-0.1+0.0+0.0-0.9+1.0
2026-06-231,0331,020🔵 -1.26%×0.9⚫ 그외-0.6억-0.6+0.0+0.0-0.6+1.2
2026-06-221,0301,033🔴 +0.29%×0.3⚫ 그외-0.1억-0.1+0.0+0.0-0.3+0.4
2026-06-191,0241,030🔴 +0.59%×0.4⚫ 그외-0.3억-0.3+0.0+0.0-0.3+0.6
2026-06-181,0081,024🔴 +1.59%×0.4⚫ 그외+0.1억+0.1+0.0+0.0-0.9+0.8
2026-06-179701,008🔴 +3.92%×0.4⚫ 그외-0.6억-0.6+0.0+0.0-0.1+0.7
2026-06-16930970🔴 +4.30%×0.5🔻 개인-1.0억-1.0+0.0+0.0+0.7+0.3
2026-06-15889930🔴 +4.61%×0.9🟢 외인+0.0억+0.0+0.0+0.0-0.0+0.0
2026-06-12841889🔴 +5.71%×0.2⚫ 그외-0.0억-0.0+0.0+0.0+0.0+0.0
2026-06-11893841🔵 -5.82%×0.4🔻 개인-0.2억-0.2+0.0+0.0+0.2+0.0
2026-06-10855893🔴 +4.44%×0.3🔻 개인-0.1억-0.1+0.0+0.0+0.1+0.0
2026-06-09779855🔴 +9.76%×0.3🟢 외인+0.1억+0.1+0.0+0.0-0.1+0.0
2026-06-08900779🔵 -13.44%×0.8🟢 외인+0.1억+0.1+0.0+0.0-0.1+0.0
2026-06-05940900🔵 -4.26%×2.0🟢 외인+1.1억+1.1+0.0+0.0-1.5+0.4
2026-06-04992940🔵 -5.24%×0.7⚫ 그외-0.3억-0.3+0.0+0.0-0.5+0.8
2026-06-02899992🔴 +10.34%×2.7⚫ 그외+1.2억+1.2+0.0+0.0-3.0+1.8
2026-06-011,091899🔵 -17.60%×7.1⚫ 그외-0.8억-0.8+0.0+0.0+0.3+0.6
2026-05-291,1151,091🔵 -2.15%×0.5⚫ 그외-0.3억-0.3+0.0+0.0+0.1+0.2

일자별 사유 (최신 위)

2026-08-06

  • 사유: —
  • 섹터 컨텍스트: KOSDAQ:일반서비스 (smart +32.4억)
  • 매크로 원인: 개별 허가·실적·정책 호재가 겹치며 바이오헬스 업종 전반 강세 확산 (낮음)

2026-06-02

  • 사유: 국산신약 직접 허가 기대감, 단 가압류·배임 손배소 악재 혼재
  • 섹터 컨텍스트: KOSDAQ:일반서비스 (smart -49.5억)
  • 매크로 원인: 공통 테마 없이 개별 재료 — 비보존제약 비마약성 진통제 발주 확대가 주도, 나머지는 시장 전반·수급 영향 (보통)